Marketing-authorisation holder · United States
ID Biomedical Corporation of Quebec
6 medicines in 1 country, as authorisation holder.
Loading your page…
Marketing-authorisation holder · United States
6 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
6 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Arepanrix0.5ml · Injection | Influenza a monovalent vaccine, adjuvanted | United States | Not marketed | 2013 |
| Flulaval, Flulaval Quadrivalent15ug/.5ml · Injection | Influenza vaccine | United States | Not marketed | 2009 |
| Flulaval, Flulaval Quadrivalent45ug/.5ml · Injection | Influenza vaccine | United States | Marketed | 2013 |
| Flulaval, Flulaval Quadrivalent45ug/.5ml · Injection | Influenza vaccine | United States | Marketed | 2006 |
| Flulaval, Flulaval Quadrivalent60ug/.5ml · Injection | Influenza vaccine | United States | Not marketed | 2013 |
| Flulaval, Flulaval Quadrivalent60ug/.5ml · Injection | Influenza vaccine | United States | Not marketed | 2013 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 6 | 6 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.